| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TEVA PHARMACEUTICAL INDS LTD | 600,200 | 30,148,000 | 7.83% | ||
| 2 | ALLERGAN PLC | 95,000 | 21,954,000 | 5.70% | ||
| 3 | SHIRE PLC | 264,539 | 21,599,000 | 5.61% | ||
| 4 | GILEAD SCIENCES INC | 192,700 | 16,075,000 | 4.17% | ||
| 5 | LILLY ELI & CO | 200,000 | 15,750,000 | 4.09% | ||
| 6 | CELGENE CORP | 155,000 | 15,288,000 | 3.97% | ||
| 7 | PFIZER INC | 426,612 | 15,021,000 | 3.90% | ||
| 8 | AMGEN INC | 85,000 | 12,933,000 | 3.36% | ||
| 9 | BIOGEN INC | 50,500 | 12,212,000 | 3.17% | ||
| 10 | MYLAN N V | 250,000 | 10,810,000 | 2.81% | ||
| 11 | ITURAN LOCATION AND CONTROL LTD | 460,452 | 10,448,000 | 2.71% | ||
| 12 | GLAXOSMITHKLINE PLC | 398,287 | 6,391,000 | 1.66% | ||
| 13 | BIOGEN INC | 250 | 6,046,000 | 1.57% | Put | |
| 14 | MERCK & CO INC | 100,000 | 5,761,000 | 1.50% | ||
| 15 | AMICUS THERAPEUTICS INC | 1,005,000 | 5,487,000 | 1.42% | ||
| 16 | GLYCOMIMETICS INC | 718,080 | 5,220,000 | 1.36% | ||
| 17 | ULTRAGENYX PHARMACEUTICAL INC COM | 105,000 | 5,136,000 | 1.33% | ||
| 18 | VERTEX PHARMACEUT | 57,600 | 4,955,000 | 1.29% | ||
| 19 | Alexion Pharma Inc | 42,323 | 4,942,000 | 1.28% | ||
| 20 | ACADIA HEALTHCARE COMPANY IN | 1,500 | 4,869,000 | 1.26% | Call | |
| 21 | ACHAOGEN INC | 1,257,366 | 4,765,000 | 1.24% | ||
| 22 | CORVUS PHARMACEUTICALS INC COM | 325,053 | 4,577,000 | 1.19% | ||
| 23 | ADVANCE AUTO PARTS INC | 27,662 | 4,471,000 | 1.16% | ||
| 24 | NEURODERM LTD | 258,513 | 4,201,000 | 1.09% | ||
| 25 | GILEAD SCIENCES INC | 500 | 4,171,000 | 1.08% | Call | |
| 26 | ADAMAS PHARMACEUTICALS INC | 270,000 | 4,088,000 | 1.06% | ||
| 27 | COLUCID PHARMACEUTICALS INC COM | 500,137 | 4,086,000 | 1.06% | ||
| 28 | TESARO INC | 450 | 3,782,000 | 0.98% | Call | |
| 29 | KERYX BIOPHARMACEUTICALS INCORPORATED | 562,900 | 3,726,000 | 0.97% | ||
| 30 | CHARTER COMM | 16,065 | 3,673,000 | 0.95% | ||
| 31 | GW PHARMACEUTICALS PLC | 40,000 | 3,663,000 | 0.95% | ||
| 32 | B COMMUNICATIONS LTD | 148,861 | 3,556,000 | 0.92% | ||
| 33 | MACROGENICS INC | 130,000 | 3,509,000 | 0.91% | ||
| 34 | Ascendis Pharma | 261,800 | 3,474,000 | 0.90% | ||
| 35 | ALNYLAM PHARMACEUTICALS INC | 600 | 3,329,000 | 0.86% | Put | |
| 36 | RADIUS HEALTH | 90,000 | 3,308,000 | 0.86% | ||
| 37 | SAGE THERAPEUTICS INC | 1,000 | 3,013,000 | 0.78% | Call | |
| 38 | EIGER BIOPHARMACEUTICALS INC | 150,716 | 2,987,000 | 0.78% | ||
| 39 | ALPHABET INC | 4,162 | 2,928,000 | 0.76% | ||
| 40 | GENOCEA BIOSCIENCES INC | 709,271 | 2,908,000 | 0.75% | ||
| 41 | GW PHARMACEUTICALS PLC | 310 | 2,839,000 | 0.74% | Call | |
| 42 | VISA INC | 37,966 | 2,816,000 | 0.73% | ||
| 43 | Alder Biopharmaceutl | 112,500 | 2,809,000 | 0.73% | ||
| 44 | CLOVIS ONCOLOGY INC | 200,000 | 2,744,000 | 0.71% | ||
| 45 | RETROPHIN INC COM | 150,000 | 2,672,000 | 0.69% | ||
| 46 | KITE PHARMA INCORPORATED | 50,000 | 2,500,000 | 0.65% | ||
| 47 | ACORDA THERAPEUTICS | 98,000 | 2,499,000 | 0.65% | ||
| 48 | MEDGENICS INC | 450,000 | 2,498,000 | 0.65% | ||
| 49 | FIVE PRIME THERAPEUTICS INC | 60,000 | 2,481,000 | 0.64% | ||
| 50 | RELYPSA INC | 130,000 | 2,405,000 | 0.62% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001178913-16-006167, filed 2016.08.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
